Deviations A written authorization, granted after contract award and prior to the manufacture of the item, to depart from a particular performance or design requirement of a contract, specification, or referenced document, for a specific number of units or a specified period of time. Deviations are intended only as one-time departures from an established configuration for specified items or lots and are not intended to be repeatedly used in place of formal engineering changes. BATC shall devise a system to control, monitor, and notify DigitalGlobe of these changes. The control system shall include provision for:
Site Visits and Inspections; Regulatory Examinations During the term of this Agreement, authorized representatives of the Fund may conduct periodic site visits of the Transfer Agent’s facilities and inspect the Transfer Agent’s records and procedures solely as they pertain to the Transfer Agent’s services for the Fund under or pursuant to this Agreement. Such inspections shall be conducted at the Fund’s expense (which shall include costs related to providing materials, copying, faxing, retrieving stored materials, and similar expenses) and shall occur during the Transfer Agent’s regular business hours and, except as otherwise agreed to by the parties, no more frequently than twice a year. In connection with such site visit and/or inspection, the Fund shall not attempt to access, nor will it review, the records of any other clients of the Transfer Agent and the Fund shall conduct the visit/inspection in a manner that will not interfere with the Transfer Agent’s normal and customary conduct of its business activities, including the provision of services to the Fund and to other clients. The Transfer Agent shall have the right to immediately require the removal of any Fund representatives from its premises in the event that their actions, in the reasonable opinion of the Transfer Agent, jeopardize the information security of its systems and/or other client data or otherwise are disruptive to the business of the Transfer Agent. The Transfer Agent may require any persons seeking access to its facilities to provide reasonable evidence of their authority. The Transfer Agent may also reasonably require any of the Fund’s representatives to execute a confidentiality agreement before granting such individuals access to its facilities. The Transfer Agent will also provide reasonable access to the Fund’s governmental regulators, at the Fund’s expense, solely to (i) the Fund’s records held by the Transfer Agent and (ii) the procedures of the Transfer Agent directly related to its provision of services to the Fund under the Agreement.
Budgets Borrower shall have delivered, and Lender shall have approved, the Annual Budget for the current Fiscal Year.
Hardware and Software Requirements In order to access and retain Disclosures electronically, you must satisfy the following computer hardware and software requirements: access to the Internet; an email account and related software capable of receiving email through the Internet; a web browser which is SSL-compliant and supports secure sessions, and hardware capable of running this software.
Monitoring System In each case in which the Custodian has exercised delegated authority to place Assets with a Foreign Custodian, the Custodian shall establish a system, to re-assess or re-evaluate selected Foreign Custodians, at least annually in accordance with Rule 17f-5(c)(3).
Programming Seller shall not make any material changes in the broadcast hours or in the percentages of types of programming broadcast by the Station, or make any other material change in the Station's programming policies, except such changes as in the good faith judgment of the Seller are required by the public interest.
Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.
Regulatory Inspections Manufacturer will permit Rhythm or its agents to be present and participate in any visit or inspection by any Authority of the Facility (to the extent it relates in any way to any Product) or the Manufacturing Process. Manufacturer will give as much advance notice as reasonably possible to Rhythm of any such visit or inspection. Manufacturer will provide Rhythm with a copy of any report or other written communication * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. received from such Authority in connection with such visit or inspection, and any written communication received from any Authority relating to any Product, the Facility (if it relates to or affects the Development and/or Manufacture of Product) or the Manufacturing Process, within two (2) business days after receipt, and will consult with, and require approval from, Rhythm before responding to each such communication. Manufacturer will provide Rhythm with a copy of its final responses within five (5) business days after submission.
Technical Specifications Each Bloom System is an integrated system comprised of a fuel cell stack assembly and associated balance of plant components that converts a fuel into electricity using electrochemical means that (i) has a Nameplate Capacity of at least 0.5 kilowatts of electricity using an electrochemical process and (ii) has an electricity-only generation efficiency greater than thirty percent (30%).
Frequency MONTHLY SUGGESTED FUND AUDITOR (A) FUNCTION INVESTORS BANK NYLIM OR FUND COUNSEL (C) ----------------------------------- --------------------------------- -------------------------------- --------------------------- Perform asset Diversification Perform asset diversification Review test results and take A - Provide consultation as testing to Establish qualification tests at each tax quarter end. any necessary action. Approve needed in establishing as a RIC. Timely report potential tax positions taken. positions to be taken in violations to Fund Management. tax treatment of particular FREQUENCY: QUARTERLY Follow-up on issues. issues. Review quarter end tests on a current basis. Perform qualifying income testing Perform qualifying income testing Review test results and take A - Consult as needed on to establish qualification as a (on book basis income, unless any necessary action. Approve tax accounting positions to RIC. material differences are tax positions taken. be taken. Review in anticipated) on quarterly basis conjunction with year-end FREQUENCY: QUARTERLY and as may otherwise be audit. necessary. Timely report potential violations to Fund Management. Follow-up on issues. Calculate total return information Provide total return Review total return information. on Funds as defined in the current calculations. Provide after-tax Prospectus and SAI. calculations in connection with post-effective amendment filings. FREQUENCY: MONTHLY Prepare the Funds' annual expense Prepare preliminary expense Provide asset level budget. Establish daily accruals. budget. Notify mutual fund projections. Approve expense accounting of new accrual rates. budget. FREQUENCY: ANNUALLY SUGGESTED FUND AUDITOR (A) FUNCTION INVESTORS BANK NYLIM OR FUND COUNSEL (C) ----------------------------------- --------------------------------- -------------------------------- --------------------------- Monitor the Funds' expense budget. Monitor actual expenses updating Provide asset level projections A/C - Provide consultation Review the Funds' multi-class budgets/expenses accruals. If quarterly. Provide vendor as requested. expense differentials. applicable, review expense information as necessary. differentials among classes to Review expense analysis and FREQUENCY: MONTHLY ensure consistency with Rule approve budget revisions. 18f-3 or the Funds' exemptive application and the Funds' private letter ruling or published ruling. Receive and coordinate payment of Propose allocations of invoices Approve invoices and Fund expenses. among Funds and obtain authorized allocations of payments. Send approval to process payment. invoices to IBT in a timely FREQUENCY: AS OFTEN AS NECESSARY manner. Calculate periodic dividend rates Calculate amounts available for Establish and maintain dividend C - Review dividend to be declared in accordance with distribution. Coordinate review and distribution policies. resolutions in conjunction management guidelines. by Fund Management and/or Approve distribution rates per with Board approval. auditors. Notify custody and share and aggregate amounts. FREQUENCY: ACCORDING TO DIVIDEND transfer agent of authorized Obtain Board approval when A - Review and approve POLICY dividend rates in accordance with required. dividend calculation Board approved policy. Report methodology for multi-class dividends to Board as required. funds. Provide consultation Obtain Board approval when as requested. required.
